Home > News > Gennum Corporation Reports Second Quarter 2007 Results
June 28th, 2007
Gennum Corporation Reports Second Quarter 2007 Results
Abstract:
As a result of the new accounting standards adopted in 2007, our
investment in Nanoscience is recorded on the balance sheet at its market value
of $2.5 million. A $0.7 million loss was recorded to the opening balance of
"accumulated other comprehensive loss" (note 7 of the financial statements) to
reflect the adjustment of the investment at December 1, 2006. There was a gain
on the investment of $0.1 million recorded to other comprehensive income in
the first half of the year to reflect an upward movement in market value. The
shares of Nanoscience are traded on the AIM exchange in London, England in
British pounds and are therefore subject to foreign exchange fluctuations.
Source:
newswire.ca
Bookmark:
| Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||